Document Detail


Leuconostoc bacteremia in a healthy infant.
MedLine Citation:
PMID:  12660631     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Infections by Leuconostoc species bacteria are uncommon, and usually affect patients with an underlying disease, or those fitted with a venous catheter or subjects previously treated with vancomycin. The most common clinical presentation is fever secondary to a central venous line infection. We report a case of Leuconostoc sp. bacteremia in an otherwise apparently healthy 2.5 month-old infant. The patient was successfully treated with cefotaxime. Leuconostoc sp. is an emerging pathogen that should be considered in the differential diagnosis of vancomycin-resistant Gram-positive bacteremia.
Authors:
M Casanova-Román; J Rios; A Sánchez-Porto; J L Gomar; M Casanova-Bellido
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Minerva pediatrica     Volume:  55     ISSN:  0026-4946     ISO Abbreviation:  Minerva Pediatr.     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2003-03-27     Completed Date:  2003-08-04     Revised Date:  2006-03-28    
Medline Journal Info:
Nlm Unique ID:  0400740     Medline TA:  Minerva Pediatr     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  83-6     Citation Subset:  IM    
Affiliation:
Paediatrics Service, Hospital of La Línea, Cádiz, Spain. mcasanova@arrakis.es
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Bacterial Agents / therapeutic use
Bacteremia / drug therapy,  microbiology*
Cefotaxime / therapeutic use
Female
Gram-Positive Bacterial Infections / drug therapy,  microbiology*
Humans
Infant
Leuconostoc / isolation & purification*
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 63527-52-6/Cefotaxime

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prolonged hyperinsulinemic hypoglycemia in a small for date preterm.
Next Document:  Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children?